| 5-FU | 5-fluorouracil |
| ABCB5 | ATP-binding cassette sub-family B member-5 |
| AML | acute myeloid leukemia |
| ATM | ataxia telangiectasia mutated serine/threonine kinase |
| ATRA | all-trans retinoic acid |
| BL | Burkitt lymphoma |
| CAC | colitis-associated colon cancer |
| CC | cholangiocarcinoma |
| COX | cyclooxygenase |
| CRC | colorectal cancer |
| DHEA | dehydroepiandrosterone |
| DMAPT | dimethylamino-parthenolide |
| DNMT1 | DNA methyltransferase 1 |
| Dox | doxorubicin |
| DR | death receptor |
| DTIC | dacarbazine |
| EBV | Epstein-Barr virus |
| ER | estrogen receptor |
| FLT3 | FMS-like tyrosine kinase 3 |
| GBM | glioblastoma multiforme |
| GSH | glutathione in reduced state |
| HCC | hepatocellular carcinoma |
| HDAC1 | histone deacetylase 1 |
| HDACIs | histone deacetylase inhibitors |
| HSP | heat-shock proteins |
| IĸB | inhibitor-of-ĸB |
| IKK | IĸB complex kinase |
| JNK | c-Jun N-terminal kinase |
| MDM2 | mouse double minute 2 homolog |
| MGMT | O6-methylguanine-DNA methyltransferase |
| MITF | microphthalmia-associated transcription factor |
| MMP9 | matrix metalloproteinase 9 |
| Mn-SOD | manganese superoxide dismutase |
| NF-ĸB | nuclear transcription factor-kappa B |
| NSAID | nonsteroidal anti-inflammatory drugs |
| NSCLC | non-small-cell lung cancer |
| PARP | poly (ADP-ribose) polymerase |
| PN | parthenolide |
| ROS | reactive oxygen species |
| SAHA | suberoylanilide hydroxamic acid, vorinostat |
| SP | side-population of cells |
| TNF-α | tumor necrosis factor α |
| TRAIL | tumor necrosis factor-related apoptosis-inducing ligand |
| TRAMP | transgenic adenocarcinoma of the mouse prostate |
| VEGF | vascular endothelial growth factor |